January 2020 represented an effective markdown of about 1.7% of sales. Lockdowns implemented by many countries due to COVID-19 caused difficulty in the supply chain, which led to deferrals of some order

already has a share of intermittent renewables deployment of at least 20% or has credible evidence of programmes in place that increase the share of intermittent renewables to this level within the next 10

period. Clause 8 The particular on the issuance and delivery of the entitlement documentation of investment units shall contain at least the material information as follows: (1) provision that the

15.3% Administrative Expenses (34.5) (8.4) 308.8% Finance Costs (76.9) (93.7) -17.9% Share of Profit from Investments in Associates and Joint Ventures 339.2 659.2 -48.5% Income Tax Expense (6.3) (6.8

sales volumes plus greater main raw material costs from higher crude oil price and tight market supply. However, the overall spread margin was improved and bring 23.9% gross profit margin comparing to

comparing to 2018 or 11.9% mostly due to soften Ethylene and Glycerin price from ample supply and lower crude oil price. Summary of Performance For Q1 2019, the Company and its subsidiaries recorded net

: - Ramkhamhaeng Hospital 880.16 million baht - Chaiyapum Ram Hospital 19.09 million baht Total 899.25 million baht 1.2 Ramkhamhaeng has revenue from selling medical supply and equipment 94.57 million baht, which

profit margin was slightly brought down by 0.9% of gross profit margin due to turnaround costs and the rise of main raw material prices from tight supply plus greater crude oil prices. 2. In Q2 2018

2018, Cost of sales was 4,160 MTHB, increased by 231 MTHB comparing to 2017 or 5.9% as a result of greater Ethylene and Glycerin price from higher crude oil price and their limited supply. 2. In Q3 2018

or 17.2% due the drastic decline in Ethylene and Glycerin price from ample supply plus lower crude oil price. 2. In Q3 2019, Selling and Administrative Expenses was 361 MTHB, increased by 42 MTHB or